Medline Inc. vs Johnson & Johnson
MDLN vs JNJ — side-by-side comparison from reported financials. MDLN leads 2, JNJ leads 7 of 9 comparable metrics.
Medline Inc.
MDLN · Healthcare
$36.29+1.54%Solid
Johnson & Johnson
JNJ · Healthcare
$261.79+2.07%Mixed
| Metric | MDLN | JNJ |
|---|---|---|
| Price | $36.29 | $261.79 |
| Market cap | $31.8B | $631B |
| Revenue (TTM) | $29.9B | $97.9B |
| Revenue growth | +9.8% | +5.6% |
| Net margin | 1.7% | 21.5% |
| Free cash flow | $1.58B | $22.2B |
| Net cash (debt) | ($10.6B) | ($27.8B) |
| 1-year price return | — | +37.0% |
| P/E | 68.8 | 29.9 |
| P/E vs own history (cheap-side %) | 15% | 16% |
| Dividend yield | — | 2.00% |
| Return on equity | 5% | 26% |
| Altman Z-score | 1.65 | — |
| CV checks passed | 5 of 10 | 10 of 10 |
| Employees | 45,000 | 140,800 |
Full résumé-style profiles: MDLN CV · JNJ CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.